Human Holdings Co (2415) Q2 2026 earnings summary

Executive summary

• Revenue/net sales for the six months ended September 30, 2025, increased by 3.2% year-over-year to ¥50,730 million, with all revenue and profit items rising as planned.

• Operating income rose 9.0% to ¥1,179 million, ordinary profit grew 22.3% to ¥1,380 million, and net income attributable to shareholders increased 22.4% to ¥740 million.

• Non-operating income, including subsidies in the care business, contributed significantly to ordinary profit growth.

Financial highlights

• Revenue: ¥50,730 million (+3.2% YoY); Operating income: ¥1,179 million (+9.0% YoY); Ordinary income: ¥1,380 million (+22.3% YoY); Net income: ¥740 million (+22.4% YoY).

• Gross profit was ¥12,870 million, up from ¥12,422 million year-over-year.

• Earnings per share rose to ¥71.39 from ¥58.31 year-over-year.

• Comprehensive income for the period was ¥742 million, up from ¥612 million year-over-year.

• All major segments contributed to revenue growth, with notable increases in care, education, and other businesses.

• Operating profit margin improved to 2.3% from 2.2% year-over-year.

Outlook and guidance

• No revision to full-year guidance; record-high revenue and operating profit expected for the fiscal year ending March 2026.

• Full-year revenue forecast: ¥103,600 million (+3.3% YoY); Operating income: ¥3,600 million (+5.7% YoY); Ordinary income: ¥3,700 million (+3.5% YoY); Net income: ¥2,500 million (−4.1% YoY, due to normalized tax expenses).

• Full-year earnings per share forecast is ¥240.90.